MedPath
HSA Product

LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML

Product approved by Health Sciences Authority (SG)

Basic Information

LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML

INFUSION, SOLUTION CONCENTRATE

Regulatory Information

SIN17002P

May 8, 2024

Prescription Only

Therapeutic

INTRAVENOUS

June 19, 2024

June 4, 2025

Company Information

Genentech, Inc.

ROCHE SINGAPORE PTE. LTD.

Active Ingredients

Mosunetuzumab

Strength: 30 mg/30 ml

© Copyright 2025. All Rights Reserved by MedPath